Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-24

Clinical Trial Update: Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating Osteocel Plus in XLIF procedures for degenerative disc disease and low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osteocel Plus

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease, Back Pain | Status: COMPLETED